Видео ютуба по тегу Medicines: Inebilizumab

Inebilizumab as a Potential Therapy for Autoimmune Encephalitis
Inebilizumab as a Potential Therapy for Autoimmune Encephalitis
Inebilizumab in AQP4+ NMOSD patients with history of immunosuppression treatment: N-MOmentum study
Inebilizumab in AQP4+ NMOSD patients with history of immunosuppression treatment: N-MOmentum study
Efficacy of inebilizumab in patients with NMOSD with Fc receptor III-A polymorphisms
Efficacy of inebilizumab in patients with NMOSD with Fc receptor III-A polymorphisms
Inebilizumab Treatment in Newly Diagnosed NMOSD Patients
Inebilizumab Treatment in Newly Diagnosed NMOSD Patients
Distinctive attributes and efficacy of inebilizumab in NMOSD
Distinctive attributes and efficacy of inebilizumab in NMOSD
Consistent efficacy of inebilizumab across newly presenting and previously treated NMOSD cases
Consistent efficacy of inebilizumab across newly presenting and previously treated NMOSD cases
Bruce Cree, MD, PhD, MAS: Inebilizumab for NMOSD Treatment
Bruce Cree, MD, PhD, MAS: Inebilizumab for NMOSD Treatment
Updates on N-MOmentum: inebilizumab versus placebo in patients with NMOSD
Updates on N-MOmentum: inebilizumab versus placebo in patients with NMOSD
Inebilizumab: Proposed Mechanism of Action For Treating NMOSD
Inebilizumab: Proposed Mechanism of Action For Treating NMOSD
The Safety and Effective of Inebilizumab in African American NMOSD Patients
The Safety and Effective of Inebilizumab in African American NMOSD Patients
Bruce Cree, MD, PhD, MAS: Insights from the N-MOmentum Study of Inebilizumab
Bruce Cree, MD, PhD, MAS: Insights from the N-MOmentum Study of Inebilizumab
Bruce Cree, MD, PhD, MAS: The NMOSD Landscape After the Inebilizumab Approval
Bruce Cree, MD, PhD, MAS: The NMOSD Landscape After the Inebilizumab Approval
Analyzing Long Term, End Of Study Results for Inebilizumab Treatment in NMOSD
Analyzing Long Term, End Of Study Results for Inebilizumab Treatment in NMOSD
403. I-CAN, A Study of Inebilizumab in Children with AQP4+ NMOSD
403. I-CAN, A Study of Inebilizumab in Children with AQP4+ NMOSD
Recent progress and future needs in NMOSD treatment
Recent progress and future needs in NMOSD treatment
An overview of the current treatment options for NMOSD from ACTRIMS 2024
An overview of the current treatment options for NMOSD from ACTRIMS 2024
Long Term Benefits of Inebilizumab Revealed in N MOmentum Analysis
Long Term Benefits of Inebilizumab Revealed in N MOmentum Analysis
Bruce Cree, MD, PhD, MAS: Inebilizumab in Neuromyelitis Optica Spectrum Disorder
Bruce Cree, MD, PhD, MAS: Inebilizumab in Neuromyelitis Optica Spectrum Disorder
How do the approved NMOSD therapies work?
How do the approved NMOSD therapies work?
Effects of Inebilizumab to Treat Myasthenia Gravis
Effects of Inebilizumab to Treat Myasthenia Gravis